2 in 3 Older Adults Do Not Consult a Regular Family Doctor, Ne... - 27 July 2022 11:15

SINGAPORE, July 27, 2022 /PRNewswire-AsiaNet/ -- -New research unveiled by SMU's Centre for Research on Successful Ageing (ROSA) shows that only 35% of older adults in Singapore have a regular family doctor -Having a regular family doctor ensures 'continuity of care' and is key to preventive h...

  Menarini Silicon Biosystems and DIESSE announced strategic par... - 27 July 2022 01:03

CHICAGO, July 26, 2022 /PRNewswire-AsiaNet/ -- The commercial agreement to promote and sell CHORUS TRIO immunometric assay solutions in the U.S. Market was announced jointly by the two companies during the AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago. Menarini Silicon Biosy...

  Henlius HANQUYOU Received TGA Approval in Australia - 26 July 2022 22:26

SHANGHAI, July 26, 2022 /PRNewswire-AsiaNet/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company's business partner Cipla Limited ("Cipla") has received the relevant registration certificates from the Therapeutic Goods Administration of Australia ("TGA") for the approval of H...

  Novavax Announces Expanded Approval of Nuvaxovid(TM) COVID-19 ... - 26 July 2022 22:05

GAITHERSBURG, Md., July 26, 2022 /PRNewswire-Asianet/ -- -- Nuvaxovid(TM) is the first protein-based COVID-19 vaccine approved for use in adolescents in Japan Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for seri...

  Novavax Nuvaxovid(TM) COVID-19 Vaccine Granted Provisional Reg... - 26 July 2022 22:00

GAITHERSBURG, Md., July 27, 2022 /PRNewswire-Asianet/ -- --Nuvaxovid(TM) is the first protein-based COVID-19 vaccine available for use in adolescents aged 12 through 17 in Australia Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vacci...

  4DMedical Lauds U.S. House of Representatives for Including Bu... - 23 July 2022 03:47

LOS ANGELES, July 23, 2022 /PRNewswire-AsiaNet/ -- -- Thousands of Impacted Veterans Will Benefit from Congressional Efforts 4DMedical, the leading developer of functional imaging software for respiratory illness, today praised the U.S. House of Representatives for including language calling on...

  Vaccines alone aren't enough to combat AMR, claims new WHO report - 23 July 2022 02:49

LONDON, July 22, 2022 /PRNewswire-AsiaNet/ -- The Global Hygiene Council (GHC) calls for the use of hygiene practices, such as handwashing, alongside vaccinations to prevent the spread of infectious diseases and reduce the impact of antimicrobial resistance (AMR). A recent report [ https:...

  Karyopharm and Menarini Group Receive Full Marketing Authorisa... - 22 July 2022 00:03

NEWTON, Mass. and FLORENCE, Italy, July 21, 2022 /PRNewswire-AsiaNet/ -- – Based on Results from Phase 3 BOSTON Study, Marketing Authorisation Expands Multiple Myeloma Indication – – Approval Follows Positive Opinion by European Committee for Medicinal Products for Human Use (CHMP) in May 2022 – Karyopharm Therap...

  Oncoshot Enters Collaboration Agreement With Omico (Australian... - 20 July 2022 00:35

SINGAPORE, July 19, 2022 /PRNewswire-AsiaNet/ – Oncoshot has just entered into a collaboration agreement with Omico, the Australian Genomic Cancer Medicine Centre. The respective parties were represented at the event yesterday by Dr Huren Sivaraj, CEO and co-founder of Oncoshot, and Prof David ...

  llumina Among First in the World to Receive Approval of Scienc... - 19 July 2022 19:51

SINGAPORE, July 19, 2022 /PRNewswire-AsiaNet/ -- The Science Based Targets initiative has validated Illumina's targets to reach Net-Zero greenhouse gas emissions by 2050 Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today it i...